CCL22 and neoplasm: A mouse model confirmed that CD79A allows bone marrow-derived suppressor cells to maintain their immature state, enhances the ability to suppress T-cell proliferation, stimulates their migration, and induces the secretion of protumor cytokines such as IL-6 and CCL22, thereby promoting tumor growth [36].